Symple Surgical is an exciting start-up Medical Device company focused on developing novel therapeutic technologies through controlled Microwave Ablation. Our technologies are thoughtfully designed to be familiar and easy to use by the operator while providing superior control, feedback, and safety for the patient.
Symple Surgical’s first product offering is the DirectAblate Renal Denervation System™. Through the ground-breaking therapy of directed renal sympathetic denervation (dRDN), we are focused on helping hundreds of millions of patients worldwide living with chronic hypertension (High Blood Pressure) through. DirectAblate Renal Denervation System™ delivers microwave thermal energy directly to the precise location of overactive sympathetic nerves while minimizing thermal exposure to non-targeted tissue. Renal Denervation has proven to be a safe and effective way to treat uncontrolled Hypertension in a short one-time minimally invasive vascular procedure.
Due to the unique characteristics of Microwave Energy, wide-ranging applications for this technology cross-over into the fields of Interventional Cardiology, Electrophysiology, Nephrology, Pulmonology and Vascular Intervention. Symple Surgical has established an exciting pipeline of products targeting growing markets in minimally invasive medicine.
Symple Surgical, Inc. is a privately-held company with engineering and product development offices in Northern California and Flagstaff, AZ. We are comprised of a highly experienced team of Medical Device professionals with global experience covering research and development (R&D) through product commercialization. We are backed by a world class Scientific Advisory Board of clinicians and researches dedicated to developing therapeutic microwave technology for superior treatment of life-threatening chronic conditions